Importantly, functional incapacitation of PD-1 in gene-targeted mice (91–93) and human patients treated with blocking Abs (94) can result in overt autoimmune responses, including T1D (94–98), indicating a primarily inhibitory function of PD-1 expression in immune effector cells. Here, PDCD1 is linked to type 1 diabetes mellitus.